Aberrant methylation and decreased expression of the TGF‐β/Smad target gene FBXO32 in esophageal squamous cell carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|16|2412-2423

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.16, 2014-08, pp. : 2412-2423

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aberrant Methylation of the VIM Promoter in Uterine Cervical Squamous Cell Carcinoma

By  

Oncology, Vol. 86, Iss. 5-6, 2014-06 ,pp. : 359-368

Karger

Access to resources Recommend Favorite

Clinicopathological Significance of Human Macrophage Metalloelastase Expression in Esophageal Squamous Cell Carcinoma

By  

Oncology, Vol. 63, Iss. 4, 2002-11 ,pp. : 378-384

Karger

Access to resources Recommend Favorite

Prognostic Significance of Dysadherin Expression in Esophageal Squamous Cell Carcinoma

By  

Oncology, Vol. 67, Iss. 1, 2004-10 ,pp. : 73-80

Karger

Access to resources Recommend Favorite

NORAD Expression Is Associated with Adverse Prognosis in Esophageal Squamous Cell Carcinoma

By  

Oncology Research and Treatment, Vol. 40, Iss. 6, 2017-05 ,pp. : 370-374

Karger

Access to resources Recommend Favorite

Decreased expression of Kallmann syndrome 1 sequence gene (KAL1) contributes to oral squamous cell carcinoma progression and significantly correlates with poorly differentiated grade

By  

JOURNAL OF ORAL PATHOLOGY & MEDICINE, Vol. 44, Iss. 2, 2015-02 ,pp. : 109-114

John Wiley & Sons Inc

Access to resources Recommend Favorite